Chemotherapy versus best supportive care for extensive small cell lung cancer
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001990.pub2/epdf/full
Reference88 articles.
1. Clinical experiences with Holoxan in small ceIl carcinoma of the bronchus (authors transl);Kokron;Osterreichische Kneipp Magazin,1977
2. Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small celI lung cancer. A clinical study;Kokron;Onkologie,1982
3. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer;O'Brien;Journal of Clinical Oncology,2006
4. Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial;Spiro;British Journal of Cancer,1989
5. Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer;Allan;Cancer Chemotherapy and Pharmacology,1984
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer;Journal of Inflammation Research;2024-03
2. Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival;Journal of Thoracic Disease;2022-08
3. State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan;International Journal of Molecular Sciences;2022-06-24
4. miR-196a Upregulation Contributes to Gefitinib Resistance through Inhibiting GLTP Expression;International Journal of Molecular Sciences;2022-02-04
5. Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy;Journal of Thoracic Disease;2021-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3